News

This significant achievement underscores the company's ongoing dedication to minimizing the environmental impact of its laboratory space. 

Brain Awareness Week was originally created by the Dana Alliance for Brain Initiatives in 1995 to raise public awareness about the advancements and benefits of brain research.  

Angelini Pharma's participation in the #50MILLIONSTEPS challenge is part of a broader commitment by the company in the fight against epilepsy, a condition affecting fifty million people worldwide.

Angelini Pharma celebrates the event through the words of its researchers.

The challenge will be focused on advanced digital approaches for drug discovery.

The Headway initiative was presented at the Italian Embassy in Paris, bringing to light significant data on epilepsy in France, with a focus on the inclusion of people in the workplace.

Angelini Pharma confirms itself as Top Employer Europe, attesting its leadership in HR strategies in which we prioritize the well-being, growth, and satisfaction of its Angeliners.

In the weeks leading up to International Epilepsy Day on February 12th, Angelini Pharma is reaffirming its commitment to combating the stigma associated with epilepsy.

The Angelini Pharma’s first international standalone event on epilepsy entirely dedicated to HCPs.

Every year, on October 10th, World Mental Health Day provides a great opportunity to increase awareness on mental health issues and underline the necessity of addressing these challenges on a global scale.